Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation

Authors:

Abstract
Epstein-Barr virus (EBV) is a human cancer-related virus closely associated with lymphoid and epithelial malignancies, and EBV glycoprotein B (gB) plays an essential role in viral entry into both B cells and epithelial cells by promoting cell-cell fusion. EBV gB is exclusively modified with high-mannose-linked N-glycans and primarily localizes to the endoplasmic reticulum (ER) with low levels on the plasma membrane (PM). However, the mechanism through which gB is regulated within host cells is largely unknown. Here, we report the identification of F-box only protein 2 (FBXO2), an SCF ubiquitin ligase substrate adaptor that preferentially binds high-mannose glycans and attenuates EBV infectivity by targeting N-glycosylated gB for degradation. gB possesses seven N-glycosylation sites, and FBXO2 directly binds to these high-mannose moieties through its sugar-binding domain. The interaction promotes the degradation of glycosylated gB via the ubiquitin-proteasome pathway. Depletion of FBXO2 not only stabilizes gB but also promotes its transport from the ER to the PM, resulting in enhanced membrane fusion and viral entry. FBXO2 is expressed in epithelial cells but not B cells, and EBV infection up-regulates FBXO2 levels. In summary, our findings highlight the significance of high-mannose modification of gB and reveal a novel host defense mechanism involving glycoprotein homeostasis regulation. EBV envelope glycoprotein B (gB) is a core component of the fusion machinery and plays an essential role in viral entry. EBV gB has been characterized as a high-mannose-containing glycoprotein, but the significance of this sugar type is unknown. In this work, we report the identification of FBXO2, a glycosylation-dependent E3 ubiquitin ligase component recognizing N-linked high-mannose oligosaccharides, as a novel gB-interacting host protein that controls the levels of gB glycosylation and its membrane transport. The homogenous high-mannose type N-glycan structure as a “script” that directs the degradation of the glycosylated gB by SCFFBXO2 E3 ubiquitin ligase. Our results propose a novel host defense mechanism by which host cells sense the penetrated EBV and attenuate the infectivity of progeny virus.
Funding Information
  • National Key R&D Program of China (2017YFA0505600)
  • National Key R&D Program of China (2016YFC0902000)
  • the Key Program of the National Natural Science Foundation of China (No. 81430059)
  • National Natural Science Foundation of China (No. 81672980)

This publication has 52 references indexed in Scilit: